These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16362992)

  • 21. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.
    Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models.
    Nagata N; Iwata-Yoshikawa N; Taguchi F
    Vet Pathol; 2010 Sep; 47(5):881-92. PubMed ID: 20664013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.
    Hofmann H; Geier M; Marzi A; Krumbiegel M; Peipp M; Fey GH; Gramberg T; Pöhlmann S
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1216-21. PubMed ID: 15194496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.
    Sims AC; Baric RS; Yount B; Burkett SE; Collins PL; Pickles RJ
    J Virol; 2005 Dec; 79(24):15511-24. PubMed ID: 16306622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
    Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology of experimental SARS coronavirus infection in cats and ferrets.
    van den Brand JM; Haagmans BL; Leijten L; van Riel D; Martina BE; Osterhaus AD; Kuiken T
    Vet Pathol; 2008 Jul; 45(4):551-62. PubMed ID: 18587105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
    Tan HW; Xu YM; Lau ATY
    Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice.
    Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T
    Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
    Venkataraman T; Coleman CM; Frieman MB
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor recognition and cross-species infections of SARS coronavirus.
    Li F
    Antiviral Res; 2013 Oct; 100(1):246-54. PubMed ID: 23994189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
    Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT
    PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenetic mechanisms of severe acute respiratory syndrome.
    Guo Y; Korteweg C; McNutt MA; Gu J
    Virus Res; 2008 Apr; 133(1):4-12. PubMed ID: 17825937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.
    Tseng CT; Huang C; Newman P; Wang N; Narayanan K; Watts DM; Makino S; Packard MM; Zaki SR; Chan TS; Peters CJ
    J Virol; 2007 Feb; 81(3):1162-73. PubMed ID: 17108019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques.
    Chen Y; Liu L; Wei Q; Zhu H; Jiang H; Tu X; Qin C; Chen Z
    Virology; 2008 Nov; 381(1):89-97. PubMed ID: 18801550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS: clinical virology and pathogenesis.
    Nicholls J; Dong XP; Jiang G; Peiris M
    Respirology; 2003 Nov; 8 Suppl(Suppl 1):S6-8. PubMed ID: 15018126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of different eukaryotic cell lines to SARS-coronavirus.
    Hattermann K; Müller MA; Nitsche A; Wendt S; Donoso Mantke O; Niedrig M
    Arch Virol; 2005 May; 150(5):1023-31. PubMed ID: 15645376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.
    Hamming I; Timens W; Bulthuis ML; Lely AT; Navis G; van Goor H
    J Pathol; 2004 Jun; 203(2):631-7. PubMed ID: 15141377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.